What is the catalog number for CD4 Recombinant Antibody [DB81]?

The catalog number for CD4 Recombinant Antibody [DB81] is OAAV01271-200UG.

What sizes are available for CD4 Recombinant Antibody [DB81]?

CD4 Recombinant Antibody [DB81] is available in the following size(s): 200 µg.

Is CD4 Recombinant Antibody [DB81] in stock?

CD4 Recombinant Antibody [DB81] is currently made to order / not held in immediate stock. Contact us for lead time.

CD4 Recombinant Antibody [DB81]

Product Specifications

Gene Name

CD96 antigen

Gene Aliases

1700109I12Rik; cell surface antigen CD96; T cell activation, increased late expression; t cell-activated increased late expression protein; Tact; Tactile; T-cell surface protein tactile.

Gene ID

84544

Swiss Prot

P27512

Reactivity

Mouse

Immunogen

This antibody was raised by immunising rats with murine CD96.

Clonality

Recombinant Monoclonal

Type

Recombinant Monoclonal Antibody

Purification

Purified

Assay Protocol

Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol

Dilution

May be involved in adhesive interactions of activated T and NK cells during the late phase of the immune response. Promotes NK cell-target adhesion by interacting with PVR present on target cells. May function at a time after T and NK cells have penetrated the endothelium using integrins and selectins, when they are actively engaging diseased cells and moving within areas of inflammation (By similarity) .